IL-10, But Not IL-4, Suppresses Infection-Stimulated Bone Resorption In Vivo1

Periapical bone resorption occurs following infection of the dental pulp and is mediated mainly by IL-1α in the murine model. The production and activity of IL-1α is modulated by a network of regulatory cytokines, including those produced by Th1 (pro-inflammatory) and Th2 (anti-inflammatory) subset T cells. This study was designed to assess the functional role of the Th2-type cytokines IL-4 and IL-10 in infection-stimulated bone resorption in vivo. The dental pulps of the first molars were exposed and infected with a mixture of four common endodontic pathogens, and bone destruction was determined by micro-computed tomography at sacrifice on day 21. The results demonstrate that IL-10−/− mice had significantly greater infection-stimulated bone resorption in vivo compared with wild-type mice (p < 0.001), whereas IL-4−/− exhibited no increased resorption. IL-10−/− had markedly elevated IL-1α production within periapical inflammatory tissues (>10-fold) compared with wild type (p < 0.01), whereas IL-4−/− exhibited decreased IL-1α production (p < 0.05). IL-10 also suppressed IL-1α production by macrophages in a dose-dependent fashion in vitro, whereas IL-4 had weak and variable effects. We conclude that IL-10, but not IL-4, is an important endogenous suppressor of infection-stimulated bone resorption in vivo, likely acting via inhibition of IL-1α expression.

[1]  K. Balto,et al.  Quantification of Periapical Bone Destruction in Mice by Micro-computed Tomography , 2000, Journal of dental research.

[2]  M. Konstan,et al.  IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. , 1999, American journal of respiratory and critical care medicine.

[3]  Kawashima,et al.  Infection‐stimulated infraosseus inflammation and bone destruction is increased in P‐/E‐selectin knockout mice , 1999, Immunology.

[4]  J. Pelletier,et al.  Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. , 1999, Arthritis and rheumatism.

[5]  T. Hamilton,et al.  Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. , 1999, Journal of immunology.

[6]  H. Weiner,et al.  IL-10 is critical in the regulation of automimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4 deficient and transgenic mice , 1998, Journal of Neuroimmunology.

[7]  M. Kopf,et al.  Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. , 1998, Journal of immunology.

[8]  A. Tumber,et al.  The cellular actions of interleukin-11 on bone resorption in vitro. , 1998, Endocrinology.

[9]  H. Tilg,et al.  IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. , 1997, Immunology today.

[10]  C. Y. Wang,et al.  Increased susceptibility of RAG-2 SCID mice to dissemination of endodontic infections , 1997, Infection and immunity.

[11]  C. Y. Wang,et al.  Bone-resorptive cytokine gene expression in periapical lesions in the rat. , 1997, Oral microbiology and immunology.

[12]  M. Hernández-Garay,et al.  Depletion of endogenous interleukin-10 augments interleukin-1 beta secretion by Mycobacterium bovis BCG-reactive human cells , 1997, Clinical and diagnostic laboratory immunology.

[13]  B. Groner,et al.  IL‐10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes , 1996, FEBS letters.

[14]  Y. Ohmori,et al.  IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. , 1996, Journal of immunology.

[15]  T. Chambers,et al.  IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. , 1996, Journal of immunology.

[16]  M. Mochizuki,et al.  Suppression by IL-10 and IL-4 of cytokine production induced by two-way autologous mixed lymphocyte reaction. , 1996, Cytokine.

[17]  W. Domschke,et al.  Immunoregulatory properties of IL‐13 in patients with inflammatory bowel disease; comparison with IL‐4 and IL‐10 , 1996, Clinical and experimental immunology.

[18]  T. Bártfai,et al.  Subchronic glucocorticoid pretreatment reversibly attenuates IL-1β induced fever in rats; IL-6 mRNA is elevated while IL-1α and IL-1β mRNAs are suppressed, in the CNS , 1996 .

[19]  S. Nozawa,et al.  IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. , 1996, Journal of immunology.

[20]  A. Kukita,et al.  Interleukin‐10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast‐like cells in rat bone marrow culture system , 1995, Journal of cellular physiology.

[21]  Y. Koishihara,et al.  Endogenous bone‐resorbing factors in estrogen deficiency: Cooperative effects of IL‐1 and IL‐6 , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  C. Y. Wang,et al.  Immunolocalization of bone-resorptive cytokines in rat pulp and periapical lesions following surgical pulp exposure. , 1995, Oral microbiology and immunology.

[23]  P. Hart,et al.  Monocytes cultured in cytokine‐defined environments differ from freshly isolated monocytes in their responses to IL‐4 and IL‐10 , 1995, Journal of leukocyte biology.

[24]  S. Schreiber,et al.  Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. , 1995, Gastroenterology.

[25]  Peng Wang,et al.  Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.

[26]  I. Otterness,et al.  Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist. , 1995, Journal of immunology.

[27]  B. Dewald,et al.  Interleukin‐10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts , 1995, European journal of immunology.

[28]  J. Economou,et al.  Interleukin‐4 inhibits the expression of tumour necrosis factors α and β, interleukins‐1 β and ‐6 and interferon‐γ , 1995 .

[29]  J. Banchereau,et al.  Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[30]  M. Murtaugh,et al.  Interleukin‐4 suppresses inflammatory cytokine gene transcription in porcine macrophages , 1994, Journal of leukocyte biology.

[31]  C. Y. Wang,et al.  Pathogenesis of induced rat periapical lesions. , 1994, Oral surgery, oral medicine, and oral pathology.

[32]  M. Billah,et al.  IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. , 1994, Journal of immunology.

[33]  D. Lacey,et al.  Interleukin-4 inhibits bone resorption and acutely increases cytosolic Ca2+ in murine osteoclasts. , 1994, The Journal of biological chemistry.

[34]  H. Niiro,et al.  IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. , 1994, International immunology.

[35]  J. Riancho,et al.  Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures. , 1993, Biochemical and biophysical research communications.

[36]  K. Kasono,et al.  Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture. , 1993, Bone and mineral.

[37]  M. Howard,et al.  Modified immunological status of anti-IL-10 treated mice. , 1993, Cellular immunology.

[38]  M. Lotze,et al.  Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo , 1993, The Journal of experimental medicine.

[39]  C. Y. Wang,et al.  The role of interleukin-1 alpha in the pathogenesis of periapical bone destruction in a rat model system. , 1993, Oral microbiology and immunology.

[40]  Y. Abiko,et al.  Stimulation by interleukin-1 of interleukin-6 production by human periodontal ligament cells. , 1992, Archives of oral biology.

[41]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[42]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[43]  D. Lacey,et al.  Interleukin 4 inhibits murine osteoclast formation in vitro , 1991, Journal of cellular biochemistry.

[44]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.

[45]  J. Kaufman,et al.  IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. , 1991, Journal of immunology.

[46]  T. Hirano,et al.  IL-6 is produced by osteoblasts and induces bone resorption. , 1990, Journal of immunology.

[47]  G. Tosato,et al.  Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. , 1990, Blood.

[48]  C. Libert,et al.  Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice , 1990, European journal of immunology.

[49]  F. Dewhirst,et al.  Interleukin‐1β is a potent inhibitor of bone formation in vitro , 1987 .

[50]  T. Bringman,et al.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.

[51]  R. Russell,et al.  An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.

[52]  N. Kawashima,et al.  Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. , 1999, Archives of oral biology.

[53]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[54]  R. D'Souza,et al.  Periapical inflammatory responses and their modulation. , 1998, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[55]  M. Billah,et al.  Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. , 1995, The Journal of biological chemistry.

[56]  H. Tilg,et al.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. , 1994, Blood.

[57]  C. Dinarello,et al.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.

[58]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.